Robert Dreicer, MD, discusses his presentation from the 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies.
Robert Dreicer, MD, MS
Advertisement
Articles by Robert Dreicer, MD, MS
The Prostate Cancer Clinical States model was first proposed by Scher and colleagues nearly 10 years ago.
The past 2 to 3 decades saw a palpable therapeutic nihilism associated with the management of patients with advanced renal cell carcinoma (RCC), interrupted briefly by the initial excitement regarding high-dose interleukin-2.
Advertisement
Latest Updated Articles
- A Review of Data on Optimal Sequencing and Combinations of Current Therapies in Renal Cell
Published: March 4th 2011 | Updated:
- Novel Agents in the Management of Castration-Resistant Metastatic Prostate Cancer
Published: March 4th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5